Dexmedetomidine versus propofol for sedation in awake neurosurgery: respiratory and hemodynamic safety
Charlotte Levé, Fabrice Vallée, Sylvie Aubrun, Séverine Levavasseur, Mickael Rajaona, Kanssaa El Ayeb, Emmanuel Mandonnet, Cyril Touchard, Joaquim Mateo, Jérôme Cartailler, Jona Joachim · 2026
Read Dexmedetomidine versus propofol for sedation in awake neurosurgery: respiratory and hemodynamic safety by Charlotte Levé, Fabrice Vallée, Sylvie Aubrun, Séverine Levavasseur, Mickael Rajaona, Kanssaa El Ayeb, Emmanuel Mandonnet, Cyril Touchard, Joaquim Mateo, Jérôme Cartailler, Jona Joachim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13427777.txt.
Description
Charlotte Levé and colleagues compare two sedation drugs for awake brain surgery, where patients must stay rousable yet safe. Continuous sedation speeds waking but risks shallow breathing and low oxygen, so their centre swapped propofol for dexmedetomidine in April 2019.
Adults having awake craniotomy from April 2017 to July 2021 were studied before and after the switch, with 103 patients in total. The earlier group got propofol with remifentanil, while the later group got dexmedetomidine plus low-dose propofol. Low oxygen, high carbon dioxide, circulation stability, and adverse events were the measures that mattered.
Catalog record
| CREATOR | Charlotte Levé, Fabrice Vallée, Sylvie Aubrun, Séverine Levavasseur, Mickael Rajaona, Kanssaa El Ayeb, Emmanuel Mandonnet, Cyril Touchard, Joaquim Mateo, Jérôme Cartailler, Jona Joachim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |